{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:42:35Z","timestamp":1792269755778,"version":"4.4.0"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2014,1,29]],"date-time":"2014-01-29T00:00:00Z","timestamp":1390953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0087095","type":"journal-article","created":{"date-parts":[[2014,1,29]],"date-time":"2014-01-29T21:50:32Z","timestamp":1391032232000},"page":"e87095","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":215,"title":["Diabetes Mellitus and the Risk of Alzheimer\u2019s Disease: A Nationwide Population-Based Study"],"prefix":"10.1371","volume":"9","author":[{"given":"Chin-Chou","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Min","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Bang","family":"Leu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Chih","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Yi","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Hung","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Hsun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzeng-Ji","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shing-Jong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaw-Wen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Leong","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,1,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2217\/fnl.10.31","article-title":"Estimating and disclosing the risk of developing Alzheimer\u2019s disease: challenges, controversies and future directions","volume":"5","author":"JS Roberts","year":"2010","journal-title":"Future Neurol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1056\/NEJMsa1204629","article-title":"Monetary costs of dementia in the United States","volume":"368","author":"MD Hurd","year":"2013","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1365-2710.2002.00415.x","article-title":"Potential novel targets for Alzheimer pharmacotherapy: I. secretases","volume":"27","author":"AF Maiorini","year":"2002","journal-title":"J Clin Pharm Ther"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jalz.2011.02.004","article-title":"2011 Alzheimer\u2019s disease facts and figures","volume":"7","author":"W Thies","year":"2011","journal-title":"Alzheimers Dement"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1056\/NEJM200104123441501","article-title":"A reevaluation of the duration of survival after the onset of dementia","volume":"344","author":"C Wolfson","year":"2001","journal-title":"N Engl J Med"},{"key":"ref6","first-page":"85","article-title":"Guidelines for the medical treatment of patients with Alzheimer\u2019s disease","volume":"20","year":"2011","journal-title":"Acta Neurol Taiwan"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1001\/archneurol.2011.100","article-title":"Risk Factors and Preventive Interventions for Alzheimer Disease: State of the Science","volume":"68","author":"ML Daviglus","year":"2011","journal-title":"Arch Neurol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1212\/WNL.53.9.1937","article-title":"Diabetes mellitus and the risk of dementia: the Rotterdam Study","volume":"53","author":"A Ott","year":"1999","journal-title":"Neurology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1212\/01.WNL.0000140291.86406.D1","article-title":"Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study","volume":"63","author":"WL Xu","year":"2004","journal-title":"Neurology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1212\/WNL.0b013e3181ffe4f6","article-title":"Insulin metabolism and the risk of Alzheimer disease: the Rotterdam Study","volume":"75","author":"EM Schrijvers","year":"2010","journal-title":"Neurology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000064928","article-title":"Diabetes mellitus and the risk of dementia, Alzheimer\u2019s disease and vascular cognitive impairment in the Canadian Study of Health and Aging","volume":"14","author":"C MacKnight","year":"2002","journal-title":"Dement Geriatr Cogn Disord"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1001\/archneur.63.11.1551","article-title":"Diabetes mellitus and risk of developing Alzheimer disease: results from the Framingham Study","volume":"63","author":"A Akomolafe","year":"2006","journal-title":"Arch Neurol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.2337\/db09-0568","article-title":"A prospective analysis of elevated fasting glucose levels and cognitive function in older people: results from PROSPER and the Rotterdam Study","volume":"59","author":"SM Euser","year":"2010","journal-title":"Diabetes"},{"key":"ref14","unstructured":"Bureau of National Health Insurance (2001) National Health Insurance Annual Statistical Report. Taipei, Taiwan: Bureau of National Health Insurance; 2002."},{"key":"ref15","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/pds.1322","article-title":"Trends in the use of antihypertensive drugs by outpatients with diabetes in Taiwan, 1997\u20132003","volume":"16","author":"CW Chiang","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2337\/dc07-1072","article-title":"Increased risks of hip fracture in diabetic patients of Taiwan: a population-based study","volume":"31","author":"HF Chen","year":"2008","journal-title":"Diabetes Care"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"816","DOI":"10.2337\/dc08-1695","article-title":"Mortality risk of Charcot arthropathy compared with that of diabetic foot ulcer and diabetes alone","volume":"32","author":"MW Sohn","year":"2009","journal-title":"Diabetes Care"},{"key":"ref18","unstructured":"WHO Collaborating Center for Drug Statistics Methodology (2003) ATC Index with DDDs 2003. WHO: Oslo."},{"key":"ref19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d","volume":"12","author":"MF Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s disease","volume":"34","author":"G McKhann","year":"1984","journal-title":"Neurology"},{"key":"ref21","unstructured":"American Psychiatric Association (2000). Diagnostic and statistical manual of mental disorders: DSM-IV-TR, 4th Edition Text Revision ed. Washington, DC: American Psychiatric Association."},{"key":"ref22","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1253\/circj.CJ-12-0658","article-title":"Angiotensin-receptor blockers and risk of Alzheimer\u2019s disease in hypertension population\u2013a nationwide cohort study","volume":"77","author":"CY Hsu","year":"2013","journal-title":"Circ J"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(02)01486-3","article-title":"Ageing and diabetes: implications for brain function","volume":"441","author":"GJ Biessels","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0166-2236(95)93897-7","article-title":"Radical AGEing in Alzheimer\u2019s disease","volume":"18","author":"MA Smith","year":"1995","journal-title":"Trends Neurosci"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0166-2236(00)01656-8","article-title":"Cognition and synaptic plasticity in diabetes mellitus","volume":"23","author":"WH Gispen","year":"2000","journal-title":"Trends Neurosci"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1212\/WNL.0b013e31822f0435","article-title":"Glucose tolerance status and risk of dementia in the community: the Hisayama study","volume":"77","author":"T Ohara","year":"2011","journal-title":"Neurology"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"11120","DOI":"10.1523\/JNEUROSCI.2860-04.2004","article-title":"Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: implications for Alzheimer\u2019s disease intervention","volume":"24","author":"L Zhao","year":"2004","journal-title":"J Neurosci"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1474-4422(04)00681-7","article-title":"Insulin and neurodegenerative disease: shared and specific mechanisms","volume":"3","author":"S Craft","year":"2004","journal-title":"Lancet Neurol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S0196-9781(97)00198-8","article-title":"Selective, physiological transport of insulin across the blood-brain barrier: novel demonstration by species-specific radioimmunoassays","volume":"18","author":"WA Banks","year":"1997","journal-title":"Peptides"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2125.2010.03830.x","article-title":"Diabetes mellitus and Alzheimer\u2019s disease: shared pathology and treatment?","volume":"71","author":"K Akter","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1111\/j.1464-5491.2011.03464.x","article-title":"Insulin resistance and pathological brain ageing","volume":"28","author":"B Cholerton","year":"2011","journal-title":"Diabet Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.neuropharm.2011.01.033","article-title":"Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer\u2019s-like changes","volume":"60","author":"A Gupta","year":"2011","journal-title":"Neuropharmacology"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1047-2797(02)00464-7","article-title":"Impact of antidiabetic medications on physical and cognitive functioning of older Mexican Americans with diabetes mellitus: a population-based cohort study","volume":"13","author":"JH Wu","year":"2003","journal-title":"Ann Epidemiol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1212\/01.wnl.0000324925.95210.6d","article-title":"Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology","volume":"71","author":"MS Beeri","year":"2008","journal-title":"Neurology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1474-4422(04)00683-0","article-title":"Is Alzheimer\u2019s disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics","volume":"3","author":"JC de la Torre","year":"2004","journal-title":"Lancet Neurol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The clinical dementia rating (CDR): current version and scoring rules","volume":"43","author":"JC Morris","year":"1993","journal-title":"Neurology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1212\/WNL.42.1.115","article-title":"Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham study","volume":"42","author":"DL Bachman","year":"1992","journal-title":"Neurology"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0087095","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T19:56:12Z","timestamp":1588967772000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0087095"}},"subtitle":[],"editor":[{"given":"Massimo","family":"Pietropaolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,1,29]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,1,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0087095","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,29]]}}}